From Surf Wiki (app.surf) — the open knowledge base
Alkem Laboratories
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.
| Column 1 | Column 2 |
|---|---|
| This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Alkem Laboratories" – news · newspapers · books · scholar · JSTOR (March 2026) (Learn how and when to remove this message) |
| Column 1 |
|---|
| Public |
| BSE: 539523NSE: ALKEM |
| Pharmaceuticals |
| 1973 (1973) |
| Samprada Singh |
| Mumbai, Maharashtra, India |
| .mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}Basudeo N. Singh (Chairman)Vikas Gupta (CEO)Sandeep Singh (MD) |
| PharmaceuticalsGeneric drugsOver-the-counter drugsVaccinesDiagnosticsContact lensesanimal health |
| ₹12,964 crore (US$1.5 billion) (2025) |
| ₹2,512 crore (US$300 million) (2025) |
| ₹2,165 crore (US$260 million) (2025) |
| ₹17,691 crore (US$2.1 billion) (2025) |
| ₹12,433 crore (US$1.5 billion) (2025) |
| 20,000 (2024) |
| Pharmacor Limited, Connect2clinic, Alkem Foundation |
| www.alkemlabs.com |
| Footnotes / referencesFinancials as of 31 March 2025. |
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.
Samprada Singh was the founder and chairman emeritus of the company; he had a B.Com degree from Patna University. His brother, Basudeo Narayan Singh, was also the co-founder of the company.
Alkem set up its research and development facility for ANDA development at Taloja in 2003. In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.
In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.
Samprada Singh (1925–2019) died on 27 July 2019 at the age of 94 after a brief illness in Mumbai. In 2018, he was the 46th richest person in India.
Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.
Ask Mako anything about Alkem Laboratories — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report